Höglund, K., Kern, S., Zettergren, A., Börjesson-Hansson, A., Zetterberg, H., Skoog, I., & Blennow, K. (2017). Preclinical amyloid pathology biomarker positivity: Effects on tau pathology and neurodegeneration. Transl Psychiatry.
Citação norma ChicagoHöglund, K., S. Kern, A. Zettergren, A. Börjesson-Hansson, H. Zetterberg, I. Skoog, and K. Blennow. "Preclinical Amyloid Pathology Biomarker Positivity: Effects On Tau Pathology and Neurodegeneration." Transl Psychiatry 2017.
MLA CitationHöglund, K., et al. "Preclinical Amyloid Pathology Biomarker Positivity: Effects On Tau Pathology and Neurodegeneration." Transl Psychiatry 2017.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.